Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Depreciation and Depletion (2021 - 2025)

Historic Depreciation and Depletion for Oncology Institute (TOI) over the last 5 years, with Q3 2025 value amounting to $1.0 million.

  • Oncology Institute's Depreciation and Depletion rose 2575.0% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year increase of 2979.14%. This contributed to the annual value of $3.2 million for FY2024, which is 1145.25% up from last year.
  • Oncology Institute's Depreciation and Depletion amounted to $1.0 million in Q3 2025, which was up 2575.0% from $1.0 million recorded in Q2 2025.
  • Over the past 5 years, Oncology Institute's Depreciation and Depletion peaked at $1.0 million during Q2 2025, and registered a low of $165000.0 during Q1 2021.
  • In the last 5 years, Oncology Institute's Depreciation and Depletion had a median value of $601000.0 in 2023 and averaged $603052.6.
  • In the last 5 years, Oncology Institute's Depreciation and Depletion surged by 13257.0% in 2023 and then plummeted by 1247.26% in 2024.
  • Oncology Institute's Depreciation and Depletion (Quarter) stood at $263000.0 in 2021, then surged by 74.9% to $460000.0 in 2022, then skyrocketed by 75.65% to $808000.0 in 2023, then grew by 15.47% to $933000.0 in 2024, then grew by 7.82% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q3 2025, $1.0 million for Q2 2025, and $1.0 million during Q1 2025.